Health
New drug targeting DNA repair shows promise in range of advanced cancers – Science Codex
A new precision drug which stops cancer from repairing its DNA has shown promise in an early-stage clinical trial – highlighting the potential of a new class of drugs known as ATR inhibitors.
The drug candidate, tested in humans for the first time, was shown to be well tolerated and stopped the growth of tumours in over half of patients treated.
People in the trial had a range of advanced, heavily pre-treated cancers including breast, bowel and prostate tumours. It is remarkable to see the ne…
-
Noosa News23 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
Business23 hours agoWant passive income? These ASX dividend stocks could help
-
General23 hours agoBudget blowout ‘modest’ for Australia’s Olympic hosts
-
General23 hours agoEngland’s Harry Brook will rein in batting technique in effort to save Ashes series